BTIG Maintains Buy on Edwards Lifesciences, Raises Price Target to $115

Benzinga · 1d ago
BTIG analyst Marie Thibault maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $110 to $115.